CAMBRIDGE, Mass. & HOUSTON-- -- ARIAD Pharmaceuticals, Inc. and Bellicum Pharmaceuticals, Inc. today announced a restructuring of their license agreement for ARIAD's cell-signaling technology.
http://ift.tt/1rRwUjY
http://ift.tt/1rRwUjY
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
No comments:
Post a Comment